MedTrace Logo

Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema

NCT00320814 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2011-06-10

No results posted yet for this study

Summary

To assess the ocular and systemic safety and tolerability of a single intravitreal injection of VEGF Trap in patients with diabetic macular edema.

Conditions

Interventions

DRUG

VEGF Trap-Eye

single IVT injection of 4.0 mg of VEGF Trap-Eye into the study eye on Day 1

Sponsors & Collaborators

Principal Investigators

  • Avner Ingerman, MD · Regeneron Pharmaceuticals

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00320814 on ClinicalTrials.gov